{"title":"A study of prescription pattern in the drug therapy of chronic kidney disease","authors":"Kiran A Kantanavar, R. Holla, Shobhana Nayak Rao","doi":"10.7439/IJPR.V7I4.4024","DOIUrl":null,"url":null,"abstract":"Objectives: a) To analyze the pattern of drug prescription for chronic kidney disease and its co-morbid conditions, if exist. b) To study the rationality of drug therapy.Methodology: Over a period of 1 year, the discharge-summary records of 188 patients with CKD, admitted to nephrology wards of Justice K. S. Hegde Charitable Hospital, Mangaluru, were scrutinized and the data collected in a specially designed proforma. Descriptive analysis of the data was done.Results: Of the total 188 patients, 101(53.7%) were males and 87 (46.3%) females. Highest numbers of patients were in the age group of 58-67 years (29.3%). Hypertension was the most common co-morbidity (82%) observed, followed by anaemia (54.8%) and type 2 diabetes (43%). A total of 1436 drugs were prescribed to 188 CKD patients. Each patient received an average of 7.6 drugs. Polypharmacy was seen in all patients. Drugs acting on the cardiovascular system constituted the bulk of the prescriptions (31%) followed by nutritional Supplements (15.3%), haematinics (10.7%) and the drugs acting on gastrointestinal system (10.3%). Other important categories of drugs prescribed included antimicrobials (5.8%), antiplatelets and hypolipidaemic agents (5%), antidiabetic drugs (4.7%) and phosphate binders (4%).Conclusion: This study shows that the management of chronic kidney disease in the nephrology department of Justice K. S. Hegde Charitable Hospital, is in congruity with the rational utilization of medicines which is based on the clinical knowledge, expertise and the guidelines accessible in the field of nephrology practice.","PeriodicalId":14194,"journal":{"name":"International Journal of Pharmacological Research","volume":"1 1","pages":"81-87"},"PeriodicalIF":0.0000,"publicationDate":"2017-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmacological Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7439/IJPR.V7I4.4024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Objectives: a) To analyze the pattern of drug prescription for chronic kidney disease and its co-morbid conditions, if exist. b) To study the rationality of drug therapy.Methodology: Over a period of 1 year, the discharge-summary records of 188 patients with CKD, admitted to nephrology wards of Justice K. S. Hegde Charitable Hospital, Mangaluru, were scrutinized and the data collected in a specially designed proforma. Descriptive analysis of the data was done.Results: Of the total 188 patients, 101(53.7%) were males and 87 (46.3%) females. Highest numbers of patients were in the age group of 58-67 years (29.3%). Hypertension was the most common co-morbidity (82%) observed, followed by anaemia (54.8%) and type 2 diabetes (43%). A total of 1436 drugs were prescribed to 188 CKD patients. Each patient received an average of 7.6 drugs. Polypharmacy was seen in all patients. Drugs acting on the cardiovascular system constituted the bulk of the prescriptions (31%) followed by nutritional Supplements (15.3%), haematinics (10.7%) and the drugs acting on gastrointestinal system (10.3%). Other important categories of drugs prescribed included antimicrobials (5.8%), antiplatelets and hypolipidaemic agents (5%), antidiabetic drugs (4.7%) and phosphate binders (4%).Conclusion: This study shows that the management of chronic kidney disease in the nephrology department of Justice K. S. Hegde Charitable Hospital, is in congruity with the rational utilization of medicines which is based on the clinical knowledge, expertise and the guidelines accessible in the field of nephrology practice.
目的:a)分析慢性肾脏疾病及其合并症的药物处方模式。b)研究药物治疗的合理性。方法:对Mangaluru Justice K. S. Hegde慈善医院肾内科病房收治的188例CKD患者的出院总结记录进行了1年的审查,并以专门设计的形式收集了数据。对数据进行描述性分析。结果188例患者中,男性101例(53.7%),女性87例(46.3%)。患者以58 ~ 67岁年龄组最多(29.3%)。高血压是最常见的合并症(82%),其次是贫血(54.8%)和2型糖尿病(43%)。188例CKD患者共使用1436种药物。每位患者平均服用7.6种药物。所有患者均出现多药现象。作用于心血管系统的药物占处方的大部分(31%),其次是营养补充剂(15.3%)、血液制剂(10.7%)和胃肠道药物(10.3%)。其他重要的处方药物类别包括抗菌药(5.8%)、抗血小板和降血脂药物(5%)、抗糖尿病药物(4.7%)和磷酸盐结合剂(4%)。结论:黑格德正义慈善医院肾内科对慢性肾病的管理符合以临床知识、专业知识和肾内科实践指南为基础的合理用药。